ไทย
Research and Release
Real-World Impact: In-Depth Success Stories Showcasing the Life-Changing Benefits of Our Stem Cell Solutions
Release
Hematopoietic stem cells in the bloodstream are blood-forming stem cells that continuously circulate in the body in small amounts. However, when the body receives cytokines that stimulate bone marrow activity, such as G-CSF (a naturally occurring factor that stimulates stem cell production), or during bone marrow recovery after chemotherapy, the number of these blood-forming stem cells in the bloodstream increases rapidly. Transplanting stem cells collected from the bloodstream tends to engraft more quickly than using stem cells from bone marrow, possibly because they contain more mature blood-forming stem cells. When we refer to ‘stem cell transplants,’ it usually means the transplantation of stem cells from the bloodstream. Although the natural habitat of stem cells is the bone marrow, we can induce them to exit the bone marrow and enter the bloodstream, where they can be collected more easily.
Procedure for Collecting Autologous Stem Cells from the Bloodstream
Consult with a doctor for medical history and physical examination.
Administer G-CSF injection for 5 days to stimulate stem cell production from the bone marrow.
Full PBSCs by apheresis and Autiminiwith 350 cc blood.
Send to THAI StemLife laboratory for stem cell isolation/cultivation.
Store stem cells cryogenically at a temperature of -196°C.
Retrieve stem cells for use.
Over 105 lives SAVED!
SAVING a LIFE
Nothing vouches better than a release and use of a Cord Blood unit in a successful bone marrow transplantation ultimately SAVING a LIFE, something that no other private stem cell bank in Thailand has accomplished.
THAI StemLife Cord Blood Release Record as of September 2022 Most releases by a SINGLE Stem Cell Bank in Thailand, SE Asia and the whole of Asia!
25 RELEASES
ASD: Autistic Spectrum Disorder; IEM: Inborn Errors of Metabolism; CP: Cerebral Palsy;
HIE: Hypoxic Ischemic Encephalopathy
ADULT Stem Cell PBSC Releases as of September 2020
MM: Multiple Myelome; MS: Multiple Sclerosis; ALL: Acute Lymphocytic Leukemia; OA: Osteoarthritis
40 Releases of Autologous PBSC to Self for Osteoarthritis treatments at Private Hospitals & Police General Hospital Thailand as part of our Thai Medical Council approved Osteoarthritis study that resulted in 6 peer reviewed international publications, to dated cited more than 108 times. 25 Releases of Autologous PBSC to Self for Diabetes Mellitus ulcer treatments at Private Hospitals.
Thailand as part of our NIA 2006 Top Innovation Award study. This list shows releases by THAI StemLife, to support the treatment of various diseases. This should not be used as a reference for the list of treatable diseases by stem cells. In addition, banking your baby’s cord blood/lining/tissue does not guarantee that the stem cells will provide a cure or be applicable for every situation. The use is ultimately determined by the treating physician.
Over 105 lives SAVED!
In 2007, THAI StemLife provided autologous umbilical cord blood stem cells along with G-CSF in CEREBRAL PALSY. Peer review publication in 2011; to date, cited internationally 57 times.
In 2008, THAI StemLife provided autologous peripheral blood stem cells to heal DIABETIC ULCERS.
In 2003, THAI StemLife provided Cord Blood Stem Cells from a SAVIOR sibling achieved through IVF at our sister company Superior ART, for Bone Marrow Transplantation in THALASSEMIA. To date, another 15 babies have been born at Superior ART and their cord blood stem cells have cured Thalassemia in 15 affected siblings to date! To date, 15 out of 100 successful cases worldwide have been provided by THAI StemLife
In 2009, we provided autologous peripheral blood stem cells for bone marrow transplantation in MULTIPLE SCLEROSIS (MS).
We provided autologous peripheral blood stem cells for studies in KNEE OSTEOARTHRITIS since 2013. All our six publications have been cited internationally over 140 times!
In 2014, we studied how autologous peripheral blood stem cells work in CARTILAGE REGENERATION in 2014. Our publication has been cited internationally 42 times!
In 2017, we conducted a randomized controlled study of autologous peripheral blood stem cells in KNEE OSTEOARTHRITIS that was approved by the Thai Ministry of Public Health and the Thai Medical Council. Our publication has been cited internationally 28 times!
Case
Moving Forward: The Hope of Placental and Umbilical Cord Stem Cells in Treating Children with Walking Difficulties
May 2024
Kostas I. Papadopoulos, MD PhD
Marjo and Matinn defy Thalassemia with the help of THAI StemLife and Superior ART
February 2023
Kostas I. Papadopoulos, MD PhD
Advancing Diabetic Ulcer Treatment with Groundbreaking Stem Cell Research Supported by the National Innovation Agency
December 2009
Kostas I. Papadopoulos, MD PhD
THAI StemLife
Address: 566/3 Soi Ramkhamhaeng 39 (Thepleela 1), Prachaouthit Rd., Wangthonglang, Wangthonglang, Bangkok 10310.
Newsletter
Subscribe to get notified about product launches, special offers and company news.